kirsty (previously kixelle)
biosimilar collaborations ireland limited - insúlín aspart - sykursýki - lyf notuð við sykursýki - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
roctavian
biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).
lomudal augndropar, lausn 20 mg/ml
stada arzneimittel ag - sodium cromoglicate - augndropar, lausn - 20 mg/ml
fungyn (fluconazole portfarma) hart hylki 150 mg
alvogen ehf. - fluconazolum inn - hart hylki - 150 mg
lioresal stungulyf/innrennslislyf, lausn 0,5 mg/ml
novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 0,5 mg/ml
lioresal stungulyf/innrennslislyf, lausn 2 mg/ml
novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 2 mg/ml
lioresal stungulyf/innrennslislyf, lausn 50 míkróg/ml
novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 50 míkróg/ml
methotrexate orion pharma (methotrexate orion) tafla 2,5 mg
orion corporation - methotrexatum inn - tafla - 2,5 mg
actraphane
novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.